Friday, February 11, 2022

F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China


By BY GINA KOLATA from NYT Health https://ift.tt/q6MzP1f
https://ift.tt/q6MzP1f
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)